Standard & Poors, June 2011
a portfolio of office and laboratory properties serving the life science industry. Internal growth plus recent accretive acquisitions have bolstered coverage measures that now better support our intermediate
Decision Resources, Inc., Nov 2006, Pages: 26
might to encourage the codevelopment of RxDx products, a lack of obvious economic benefi t to the pharmaceutical and diagnostics industries has caused these industries to drag their feet
ICON Group International, June 2007, Pages: 392
and telecommunications technology. The technology spill off from the electronics area can also be seen in other market sectors, such as environmental products, biotech and the medical industries. Finnish-U.S. Trade
